Similar Articles
501 Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises)
502 Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
503 Recurrence of sigmoid colon cancer–derived anal metastasis: A case report and review of literature
504 Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections
505 Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
506 Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling
507 Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
508 Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
509 Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
510 Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA